Publicis launches Razorfish Health as standalone

Share this article:
Katy Thorbahn
Katy Thorbahn
It's not exactly news that Razorfish has a health practice, but the digital agency, which was acquired by Publicis last year, is making it official with the launch of Razorfish Health, an “independent, dedicated” health and wellness agency.

The shop will be headquartered in Philadelphia and headed by general manager Katy Thorbahn, who previously led the Seattle-based firm's Philly shop. She will report to David Kramer, CEO of sibling shop Digitas Health.

Razorfish chief Bob Lord said in a statement: “For more than 13 years, Katy's team has been building relationships with health clients, and it's now time to take our next step with the launch of this brand.”

“Healthcare is a different industry than any other, and that's why we're making this dedicated effort,” said Thorbahn. “Both the healthcare industry and technology in general are experiencing landmark change, and with that enormous opportunities to create direct connections with patients, caregivers and healthcare professionals.”

The shop also unveiled a redesigned website, at razorfishhealth.com, featuring “The Health Conversation,” a social tool that pulls in content from Twitter and Digg based on health categories every ten minutes, illustrating trending topics.

Share this article:

Email Newsletters

More in News

House bill would speed approval once EU OKs same product

House bill would speed approval once EU OKs ...

The Speeding Access to Already Approved Pharmaceuticals Act of 2014 would require FDA to expedite the review of pharmaceuticals that are already approved by the European Union

Rep access continues to shrink

Rep access continues to shrink

Sales reps are experiencing even more limited physician access, according to a report by Chicago consultancy ZS Associates.

Allergan touts reorg, plans to lay off 13% of workforce

Allergan touts reorg, plans to lay off 13% ...

Allergan's second-quarter earnings, and a new round of cuts, are now part of the Botox maker's record as it seeks to remain independent.